MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,856,000 | -8.6% | 60,931 | -40.6% | 0.01% | 0.0% |
| Q4 2020 | $2,030,000 | +28.2% | 102,644 | -15.4% | 0.01% | +27.3% |
| Q3 2020 | $1,583,000 | +96.2% | 121,344 | +70.6% | 0.01% | +83.3% |
| Q2 2020 | $807,000 | +0.5% | 71,144 | +26.7% | 0.01% | -14.3% |
| Q1 2020 | $803,000 | -44.1% | 56,144 | +6.4% | 0.01% | -30.0% |
| Q4 2019 | $1,436,000 | -12.4% | 52,744 | -7.9% | 0.01% | 0.0% |
| Q3 2019 | $1,639,000 | -2.4% | 57,244 | -5.3% | 0.01% | -9.1% |
| Q2 2019 | $1,679,000 | +135.8% | 60,444 | +182.0% | 0.01% | +120.0% |
| Q1 2019 | $712,000 | +18.3% | 21,431 | +3.4% | 0.01% | 0.0% |
| Q4 2018 | $602,000 | -40.0% | 20,731 | -4.9% | 0.01% | -37.5% |
| Q3 2018 | $1,003,000 | +11.3% | 21,802 | -9.5% | 0.01% | +33.3% |
| Q2 2018 | $901,000 | +23.9% | 24,102 | -2.0% | 0.01% | +20.0% |
| Q1 2018 | $727,000 | – | 24,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |